Provider of financial performance improvement software for US healthcare organisations
Standard Life Investments: 12.7%
Gordon Craig: 12.4%
Black Rock Investments: 10.1%
AEGON: 5%
Derek Paterson: 3.3%
| 2010 | 2009 | |
|---|---|---|
| Turnover: | $28.39m | $22.99m |
| Pre-tax profit: | $ 7.25m | $ 5.87m |
| EPS: | 21.8 c | 17.7 c |
More growth at Craneware 06/09/2010
Contract wins for Craneware 15/07/2010
Profiting from the pound’s problems 08/03/2010
Strong first half at Craneware 22/02/2010
Craneware 18/01/2010
Advertisement
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Advertisement
Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.
Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.
Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.
www.growthcompany.co.uk is published by Growth Company Investor Ltd (part of Vitesse Media plc).
Growth Company Investor Ltd, 50 Banner Street, London EC1Y 8ST.
